[Recent progress in the treatment of multiple myeloma].
Iida
Shinsuke
S
D000367:Age Factors; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D004164:Diphosphonates / Q000008:administration & dosage; D015195:Drug Design; D005538:Football; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011239:Prednisolone / Q000008:administration & dosage; D011719:Pyrazines / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012015:Reference Standards; D013792:Thalidomide / Q000008:administration & dosage
D018906:Antineoplastic Agents, Alkylating; D001897:Boronic Acids; D004164:Diphosphonates; D007166:Immunosuppressive Agents; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D011239:Prednisolone; D008558:Melphalan